Skip to main content

Table 3 Correlations of the B cell chemokine CXCL13 levels with clinical, laboratory, and radiological parameters in RA patient’ group

From: RETRACTED ARTICLE: Does serum B lymphocyte chemoattractant protein13 (CXCL13) level correlate with parameters of disease activity and severity in rheumatoid arthritis? Clinical and musculoskeletal ultrasonographic assessment

Parameters

r

P

Age (years)

0.15

0.26

Disease duration (months)

0.16

0.23

MS (min)

0.68

< 0.001**

SJC count

0.85

< 0.001**

TJC count

0.84

< 0.001**

pVAS

0.28

< 0.001**

ESR (mm/1st h)

0.70

< 0.001**

CRP level (mg/L)

0.23

0.09

HB (gm/dl)

− 0.46

0.01*

Platelets count (× 103/ul)

0.56

< 0.001**

RF u/ml

0.66

< 0.001**

Anti-CCP Abs titer u/ml

0.64

< 0.001**

DAS-28

0.85

< 0.001**

Total MSUS (0–36)

0.64

< 0.001**

US -SH (0–18)

0.46

< 0.001**

US-PD (0–18)

0.30

0.11

Larsen score (0–100)

0.18

0.21

  1. MS morning stiffness, SJC number of swollen joint, TJC number of tender joint, p VAS patient global assessment by visual analog scale, ESR/1st h erythrocyte sedimentation rate in the first hour, CRP C-reactive protein, HB hemoglobin, RF rheumatoid factor, Anti-CCP Abs anti-cyclic citrullinated peptide antibodies, DAS-28 28-joint disease activity score, MSUS musculoskeletal ultrasonography, SH synovial hypertrophy, PD power doppler, P > 0.05 non-significant, P < 0.05* significant, P < 0.001** highly significant